Posted by Michael Wonder on 30 Nov 2017
Prioritise investment in the PBS to improve access to all cancer medicines
30 November 2017 - Medicines Australia response to the Senate Select Committee report “Funding for Research into Cancers with Low Survival Rates”.
The 25 recommendations released in the Senate Select Committee report reveal the challenges Australia faces to ensure that all Australians get access to the treatments and medicines they need when they need them, regardless of the type of disease.
The report recommendations are a comprehensive response to the issue and cover research funding and coordination; clinical trial awareness, access and approvals for treatment; improving early detection and identification; repurposing existing medicines; fast-tracking innovative treatments and the utilisation of genomic research; patient care; costs; and navigation through the disease processes.
